Company / Revenue
LIXTE BIOTECHNOLOGY HOLDINGS, INC. Revenue History
FY2011-FY2015 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$200.0K
FY2015
5-year range
$0 / $200.0K
FY2011-FY2015
Trend
-
vs FY2014
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $0 to $200,000 over the past 3 years.
Based on SEC 10-K filings.
$200,000 in FY2015.
Improved from $0 to $200,000 over the past 3 years.
Revenue over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Company context
Key Data Points
- Altman Z-Score -11.44 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2015 | $200.0K | - |
| FY2013 | $0 | - |
| FY2012 | $0 | - |
| FY2011 | $0 | - |
As of FY2015 · SEC 10-K · Updated Jun 24, 2026